This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oluola, O.
Right arrow Articles by Weisman, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oluola, O.
Right arrow Articles by Weisman, L. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2007, p. 2198-2200, Vol. 51, No. 6
0066-4804/07/$08.00+0     doi:10.1128/AAC.00506-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Lysostaphin in Treatment of Neonatal Staphylococcus aureus Infection{triangledown}

Okunola Oluola,{dagger} Lingkun Kong, Mindy Fein, and Leonard E. Weisman*

Department of Pediatrics, Baylor College of Medicine, and Texas Children's Hospital, 6621 Fannin St., FC830.17, Houston, Texas 77030-2799

Received 24 April 2006/ Returned for modification 9 August 2006/ Accepted 26 March 2007

This study describes lysostaphin's effect against methicillin-sensitive Staphylococcus aureus in suckling rats. Standard techniques determined minimal inhibitory and bactericidal concentrations, pharmacokinetics, and efficacy. The numbers of surviving rats after vancomycin, oxacillin, and lysostaphin treatment were comparable and were different from that of controls (P < 0.00001). Lysostaphin appears effective in the treatment of neonatal S. aureus infection.

* Corresponding author. Mailing address: Baylor College of Medicine and Perinatal Center, Texas Children's Hospital, 6621 Fannin St., FC830.17, Houston, TX 77030-2799. Phone: (832) 824-1387. Fax: (832) 825-2799. E-mail: lweisman{at}bcm.edu

{triangledown} Published ahead of print on 9 April 2007.

{dagger} Present address: Division of Neonatology, Department of Pediatrics, University of Kansas Medical Center, Kansas City, KS.

Antimicrobial Agents and Chemotherapy, June 2007, p. 2198-2200, Vol. 51, No. 6
0066-4804/07/$08.00+0     doi:10.1128/AAC.00506-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Tan, Y. P., Giffard, P. M., Barry, D. G., Huston, W. M., Turner, M. S. (2008). Random Mutagenesis Identifies Novel Genes Involved in the Secretion of Antimicrobial, Cell Wall-Lytic Enzymes by Lactococcus lactis. Appl. Environ. Microbiol. 74: 7490-7496 [Abstract] [Full Text]  
  • Kokai-Kun, J. F., Chanturiya, T., Mond, J. J. (2007). Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model. J Antimicrob Chemother 60: 1051-1059 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»